Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that the officials of the company will be meeting Investors/ Analysts (Participants) on 06 December 2023. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the Regulation 30 (6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be Meeting Investors (Participants) in JM Financial India Conference on November 21, 2023 from 11.00 a.m. onwards. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is in continuation to our letter bearing Reference No. MHL/Sec&Legal/2023-24/62 dated October 30, 2023. Please find enclosed herewith the transcript of Q2 and H1FY24 Conference Call, as organized by Nuvama Wealth Management held on Monday, November 06, 2023 at 09:00 a.m. (IST) wherein the financial results of the Company for the quarter and half year ended September 30, 2023 were discussed. The same has also been uploaded on the Company''s website and can be accessed at http://www.metropolisindia.com/investors
Metropolis Healthcare to spend Rs 50-55 crore over two years to expand
The company has positioned itself as a premium diagnostics player. The premium wellness category was its fastest-growing segment in Q2 Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
This is in continuation to our letter bearing reference No: MHL/Sec&Legal/2023-24/62 dated October 30, 2023, with respect to intimation of Q2 and H1FY24 Conference Call for the quarter ended September 30, 2023, and pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 the audio recording of the Earnings call held today i.e. Monday, November 06, 2023 at 09:00 a.m. (IST) to discuss the Financials Results of Q2FY24 of the Company is available on the Company's website under the below link: https://www.metropolisindia.com/newdata/Investors/Submission-to-Stock-Exchange/2023-24/Q3/metropolis-q2fy24-earnings-call-audio.mp3
Metropolis Healthcare Results Earnings Call for Q2FY24
Conference Call with Metropolis Healthcare Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript. Metropolis Healthcare shares up 3% despite 11.9% decline in Q2 profit
The EBITDA margin was at 24.3 percent against 26.3 percent in the year-ago period. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Newspaper Publication
This is to inform you that the Company on Sunday, November 05 has published an extract of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2023 as approved by the Board of Directors of the Company in their Meeting held on Saturday, November 04, 2023. Please find enclosed , the copy published in Free Press Journal (English) and Navshakti (Marathi). Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached herewith, a Press Release titled " Metropolis'' Core-Revenue Growth (Excl. Covid & Covid Allied, PPP Contract) at Rs. 302 Crs in Q2FY24; up by 13.4 % YoY" Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached herewith, Investor presentation for the quarter ended September 30, 2023.